Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001341004-24-000072
Filing Date
2024-04-17
Accepted
2024-04-17 18:21:31
Documents
1
Group Members
ANNE WOJCICKI REVOCABLE TRUST U/A/D 9/2/09, AS AMENDED ATRUSTEE ANNE WOJCICKI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D, AMENDMENT NO. 1 sc13da1.htm SC 13D/A 94643
  Complete submission text file 0001341004-24-000072.txt   96553
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-91734 | Film No.: 24852275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 171 MAIN STREET SUITE 259 LOS ALTOS CA 94022
Business Address 171 MAIN STREET SUITE 259 LOS ALTOS CA 94022 650-209-9500
ABeeC 2.0, LLC (Filed by) CIK: 0001869643 (see all company filings)

EIN.: 000000000
Type: SC 13D/A